A case of alpha-gal syndrome: Recall urticaria and 10 years of measurements of IgE to galactose-α-1,3-galactose.

Alpha-gal syndrome IgE delayed anaphylaxis to red meat galactose-α-1,3-galactose natural history recall urticaria red meat allergy tick bite

Journal

The journal of allergy and clinical immunology. Global
ISSN: 2772-8293
Titre abrégé: J Allergy Clin Immunol Glob
Pays: United States
ID NLM: 9918453488706676

Informations de publication

Date de publication:
Aug 2024
Historique:
received: 22 01 2024
revised: 06 03 2024
accepted: 05 04 2024
medline: 17 6 2024
pubmed: 17 6 2024
entrez: 17 6 2024
Statut: epublish

Résumé

Alpha-gal IgE level can change rapidly. Reassessment of a patient's alpha-gal IgE level may be helpful in the patient's clinical follow-up. Pruritus related to the site of a previous tick bite strengthens the diagnosis of alpha-gal syndrome.

Identifiants

pubmed: 38881738
doi: 10.1016/j.jacig.2024.100280
pii: S2772-8293(24)00076-6
pmc: PMC11179084
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Pagination

100280

Informations de copyright

© 2024 The Authors.

Déclaration de conflit d'intérêts

Supported by the Independent Research Fund Denmark (grant 2034-00031B [to K.B.L-M.]), the 10.13039/501100010234Swedish Asthma and Allergy Association Research Foundation (to M.vH.), the Swedish Cancer and 10.13039/501100013499Allergy Foundation (to M.vH.), the King Gustaf V 80th Birthday Foundation (to M.vH.), the 10.13039/501100003793Swedish Heart-Lung Foundation (to M.vH.), and the Hesselman Foundation (to M.vH.). Disclosure of potential conflict of interest: K. B. Leth-Møller has received lecture fees from 10.13039/100011033Thermo Fisher Scientific. M. van Hage has received lecture fees from 10.13039/100011033Thermo Fisher Scientific and 10.13039/100004325AstraZeneca outside the submitted work. The rest of the authors declare that they have no relevant conflicts of interest. Informed patient consent for publication: Signed informed consent was obtained from the patient.

Auteurs

Katja Biering Leth-Møller (KB)

Center for Clinical Research and Prevention, Copenhagen University Hospital - Bispebjerg and Frederiksberg, Copenhagen, Denmark.

Marianne van Hage (M)

Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet, and Karolinska University Hospital, Stockholm, Sweden.
Center for Molecular Medicine, Karolinska Institutet, and Karolinska University Hospital, Stockholm, Sweden.

Allan Linneberg (A)

Center for Clinical Research and Prevention, Copenhagen University Hospital - Bispebjerg and Frederiksberg, Copenhagen, Denmark.
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

Line Lund Kårhus (LL)

Center for Clinical Research and Prevention, Copenhagen University Hospital - Bispebjerg and Frederiksberg, Copenhagen, Denmark.

Classifications MeSH